| (Values in U.S. Thousands) | Jan, 2024 | Jan, 2023 | Jan, 2022 | Jan, 2021 | Jan, 2020 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -1,150 | -4,770 | -3,930 | -2,820 | -1,880 |
| Net Income Growth | +75.89% | -21.37% | -39.36% | -50.00% | -2.17% |
Chitogenx Inc (CHNXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Chitogenx Inc. is a clinical-stage regenerative medicine company. It focuses on the development of novel therapeutic tissue repair technologies to improve tissue healing. Chitogenx Inc., formerly known as Ortho Regenerative Technologies Inc., is based in Canada.
Fiscal Year End Date: 01/31